Algogenics Logo
AI-Augmented CRO ServicesNEW

From Sequence to Synthesis

AlgoGenics automates the workflow bridging in-silico discovery and wet-lab validation. Reduce screening timelines by 70% and receive actionable, board-ready biological data packages.

Request Discovery Proposal
Or
Dr. Elena Vasquez
Prof. Marcus Chen
Dr. Aisha Patel
Dr. Jamal Okoro

Accelerating Pipelines for Top Tier Innovators At

MIT_BROADSTANFORD_BIOPASTEUR_INSTOXFORD_CRICK
01
Autonomous Core

Lead Discovery

End-to-end screen parameters setup. We identify, model target profiles, and select strategic structural matches.

02
Managed Pipeline

Wet-Lab Orchestration

Our protocol agents handle external logistics, sample ordering, and physical synthesis coordination automatically.

03
Milestone Delivery

Result Synthesis

Consolidated assay results are structured into verifiable, board-ready documentation and deep-data packages.

04
Enterprise SLA

Secure Partnership

Ironclad operational security. Complete validation run isolation protecting proprietary corporate IP rights.

Intelligence System v4.2.0

End-to-End Discovery Loop

A multi-agent autonomous chain designed to synthesize genomic raw datainto validated molecular leads in under 120 seconds.

Input Console

Pre-validated Datasets
VCF_V4.2

Neural Telemetry

System initialized. Awaiting input...
Variant Discovery & Annotation
Coverage:142x
Mapping Qual:60.0
In-Silico Protein Modeling
pLDDT Score:94.2
ΔΔG Stability:+4.1
Computational Lead Docking
Binding Aff:-9.8 kcal
Ligand Eff:0.44
Bio-Vault Secure Archiving
Latency:42ms
Encryption:GCM-256
Scientific Intelligence Synthesis
Source Count:14k+
Confidence:98.8%
Final Discovery Dossier
Dossier Size:12.4MB
Approval:Pending

Neural discovery protocol awaiting initialization

Global Nodes

Decentralized compute across 14 sovereign regions.

Neural Fusion

Proprietary bio-specific reasoning engines.

48H Turnaround

Accelerated CRO synthesis orchestration.

Closed Loop

Automated feedback from wet-lab results.

Proof of Druggability

In-Silico Target Validation

SiteMap analysis of the EGFR L858R mutant pocket confirms a high-affinity binding site for Type II inhibitors. Geometric analysis reveals a druggability score of 1.08, categorized as highly druggable.

Pocket Volume

0.92

HIGH POTENTIAL

Hydrophobicity

0.88

HIGH POTENTIAL

Enclosure

0.76

VIABLE

Structural Evidence

Site Score

1.084

S-Score > 0.8 is druggable

Drugging Potential

High

Based on ligand enclosure

Stability Shift

+4.2 kcal

L858R destabilization

3D Pocket Visualization

Interactive PDB rendering restricted to Pro nodes.

Technical Summary

Target validation is achieved by simulating the Gibbs free energy change of ligand binding across 10,000 conformational states.

Confidence Level98.4%

Reference Accessions

UniProt P00533
PDB 6VXX
ClinVar 16613
Compute Cluster: Active
Bio-Vault: Synced

© 2026 AlgoGenics - Decentralized Discovery Protocol

Built for High-Stakes Genomic Research

Everything you need to run trusted, autonomous bioinformatics workflows at scale.

Agentic Workflow Orchestration

Agents autonomously plan, execute, and iterate through multi-step genomic analyses without manual intervention.

Built-In Explainability

Every prediction comes with confidence scores, rationale reports, attention maps, and uncertainty quantification.

Real-Time Progress Tracking

Watch agents work step-by-step with live progress, intermediate results, and decision breakdowns.

Advanced Visualizations

Interactive pathway maps, variant distributions, and protein structure overlays powered by cutting-edge rendering.

Custom Report Generation

Export publication-ready reports with full methodology, statistical analysis, and bias warnings included.

Team Collaboration

Share agent runs, annotate results, and collaborate on analyses with role-based access control.

Intelligence FAQ

Common Queries

Everything you need to know about Algogenics and the transition to autonomous agentic discovery.

Traditional tools require manual step-by-step execution. Our agentic AI autonomously plans, executes, and iterates through multi-step analyses—like a bioinformatician working 24/7. They handle variant calling, pathogenicity scoring, and pathway integration in a single autonomous workflow.
AlgoGenics DaaS

From Raw Data to Accelerated Hit-to-Lead Identification.

Receive a custom Lead Candidate Dossier for your specific target.

SECURE_DATA_SILO
GLP_COMPLIANT_REPORTING